Testing a visual stimulation device in arm use after stroke
Checks whether a visual stimulation device is tolerable for adults with chronic stroke.
Plain-language title generated from the registry record
Registry title: Implementation of IVS3 for Upper Limb Motor Recovery
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106New York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT06483230
- Record updated
- 16 September 2026
- Original description
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.Read full original descriptionShow less
A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab Center
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Inclusion: Age ≥ 18 years old; English speaking; History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment; FMA-UE: 20 < x < 50 (moderate impairments); With or without hemi spatial neglect.
Exclusion: Concurrent occupational therapy being received outside of the study; Spasticity or increased tone with MAS ≥3 in the upper extremity; Unable to communicate effectively or provide informed consent; Significant visual impairments; Pregnant or incarcerated individuals.